母体原发感染后先天性巨细胞病毒感染及出生症状的早期预测:绒毛膜绒毛与羊水中巨细胞病毒聚合酶链反应的体内研究
这项单中心回顾性队列研究纳入2019年10月至2024年12月间孕14周前经血清学筛查诊断母体巨细胞病毒原发感染的孕妇422例,其中330例同时接受绒毛膜绒毛取样和羊膜腔穿刺。绒毛膜绒毛巨细胞病毒聚合酶链反应预测先天性感染的灵敏度48.28%、特异度98.34%、阳性预测值73.68%、阴性预测值95.18%;对出生症状、听力损失和长期症状的特异度与阴性预测值均较高。
要点
- 330例中绒毛膜绒毛巨细胞病毒聚合酶链反应阳性19例(5.7%),其中89.4%发生母胎传播,多发生在孕17周前(73.7%)。
- 孕早期绒毛膜绒毛、母血和尿液三项聚合酶链反应均阴性者未发生胎儿感染。
- 绒毛膜绒毛聚合酶链反应预测出生症状的特异度97.12%、阴性预测值97.74%,预测听力损失分别为96.26%和99.68%。
核心结论
- 绒毛膜绒毛巨细胞病毒聚合酶链反应对胎儿感染及出生相关症状具有高特异度和高阴性预测值。
研究设计与样本
- 单中心回顾性队列研究,纳入2019年10月至2024年12月间孕14周前经血清学筛查诊断母体巨细胞病毒原发感染的孕妇422例,其中330例同时接受绒毛膜绒毛取样和羊膜腔穿刺。
主要发现
- 330例中绒毛膜绒毛巨细胞病毒聚合酶链反应阳性19例(5.7%),与89.4%的母胎传播相关,其中73.7%发生在孕17周前。
- 孕早期绒毛膜绒毛、母血和尿液三项聚合酶链反应均阴性者未发生胎儿感染。
- 绒毛膜绒毛巨细胞病毒聚合酶链反应预测先天性感染的灵敏度48.28%、特异度98.34%、阳性预测值73.68%、阴性预测值95.18%。
- 16例出生时有症状的感染新生儿中,2例为双侧重度至极重度感音神经性听力损失(均绒毛膜绒毛聚合酶链反应阳性),5例为单侧感音神经性听力损失。
- 绒毛膜绒毛巨细胞病毒聚合酶链反应预测出生症状的特异度97.12%、阴性预测值97.74%;预测出生时感音神经性听力损失分别为96.26%和99.68%;预测长期症状分别为96.55%和99.35%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The long interval between the serologic diagnosis of maternal primary infection in the first trimester of pregnancy and the prenatal diagnosis of fetal infection by amniocentesis at 17 weeks of gestation may cause anxiety and distress. Cytomegalovirus polymerase chain reaction in chorionic villi sampled by chorionic villus sampling at 14 weeks of gestation can diagnose trophoblastic infection. OBJECTIVE: This study aimed to assess the diagnosis and prognostic value of cytomegalovirus polymerase chain reaction in chorionic villi in pregnant women with cytomegalovirus maternal primary infection for predicting vertical transmission and related symptoms at birth. STUDY DESIGN: This single-center retrospective cohort study enrolled pregnant women referred for cytomegalovirus maternal primary infection in early pregnancy identified by serologic screening before 14 weeks of gestation between October 2019 and December 2024. Secondary prevention with valaciclovir was offered. The primary outcome was vertical transmission, defined by a positive cytomegalovirus polymerase chain reaction in chorionic villi, amniotic fluid obtained by amniocentesis at 17 weeks of gestation, and neonatal saliva/urine at birth (or positive in situ hybridization in terminated pregnancies). The secondary outcomes were symptomatic congenital infection in live-born infants, defined according to the European Congenital Infection Initiative criteria, and sensorineural hearing loss. RESULTS: Overall, 422 women were diagnosed with maternal primary infection, and 330 women had both chorionic villus sampling and amniocentesis. Cytomegalovirus polymerase chain reaction was positive in the trophoblast in 19 of 330 women (5.7%) and associated with maternal-fetal transmission during the course of pregnancy in 89.4% of women, mostly before 17 weeks of gestation (73.7%). No fetal infection occurred in "triple negative cytomegalovirus polymerase chain reaction" in trophoblast, maternal blood, and urine in the first trimester of pregnancy. Overall, the sensitivity, specificity, positive predictive value, and negative predictive value of cytomegalovirus polymerase chain reaction in trophoblast to predict congenital infection were 48.28%, 98.34%, 73.68%, and 95.18%. Among the 16 infected newborns who were symptomatic at birth, 2 had bilateral severe-to-profound sensorineural hearing loss (all with positive cytomegalovirus polymerase chain reaction in chorionic villi), and 5 had unilateral sensorineural hearing loss. The specificity and negative predictive values of cytomegalovirus polymerase chain reaction on trophoblasts to predict symptoms at birth were 97.12% and 97.74%, respectively; 96.26% and 99.68% for sensorineural hearing loss at birth, respectively; and 96.55% and 99.35% for long-term symptoms, respectively. CONCLUSION: Cytomegalovirus polymerase chain reaction on chorionic villi showed high specificity and negative predictive value for fetal infection and related symptoms at birth.
引用
- Bourgon N, Fourgeaud J, Daclin C, et al. Early prediction of congenital cytomegalovirus infection and symptoms after maternal primary infection: an in vivo study using cytomegalovirus polymerase chain reaction in chorionic villi and in amniotic fluid. Am J Obstet Gynecol. 2025. PMID: 41265737. doi:10.1016/j.ajog.2025.11.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。